Astellas Pharma GmbH    

 

Address:

Postfach 50 01 66

Muenchen, D-80971

Germany

Phone:
49 089 45 4401

Company description

Manufacturing: Manufacture and sale of pharmaceuticals

Log in for comprehensive information about this and hundreds of thousands of other companies.

News and information about Astellas Pharma GmbH

Wipo Publishes Patent of Astellas Pharma and National Cancer Center for "Detection of Cldn18-Arhgap6 Fusion Gene or Cldn18-Arhgap26 Fusion Gene in Pancreatic Cancer" (Japanese Inventor)
US Fed News Service, Including US State News; February 19, 2018; 480 words
...invention: "DETECTION OF CLDN18-ARHGAP6 FUSION GENE OR CLDN18-ARHGAP26 FUSION GENE IN PANCREATIC CANCER."Applicants: ASTELLAS PHARMA INC. (JP) and NATIONAL CANCER CENTER (JP).Inventors: Hiroki Sasaki (JP).According to the abstract* posted by...
Uspto Issues Trademark: Qegrity
US Fed News Service, Including US State News; February 14, 2018; 251 words
...trademark QEGRITY (Reg. No. 5377480; International Reg. No 1360228) was issued on Jan. 16 by the USPTO.Owner: Astellas Pharma Inc. CORPORATION JAPAN 5-1, Nihonbashi-Honcho 2-chome, Chuo-ku Tokyo 103-8411 JAPAN.The trademark application...
Astellas Pharma and Pfizer Release Results of Its Phase 3 Prosper Trial of Xtandi
Health & Beauty Close-Up; February 8, 2018; 700+ words
Astellas Pharma and Pfizer reported results from the Phase 3 Prosper trial in patients with non-metastatic (M0) Castration-Resistant Prostate...
Astellas Pharma and Pfizer Release Results from Phase 3 of Prosper Trial of Xtandi
Health & Beauty Close-Up; February 7, 2018; 700+ words
Astellas Pharma and Pfizer reported results from the Phase 3 Prosper trial in patients with non-metastatic (M0) Castration-Resistant Prostate...
Wipo Publishes Patent of Astellas Pharma for "Piperazine Derivative" (Japanese Inventors)
US Fed News Service, Including US State News; January 28, 2018; 422 words
...Publication No. WO/2018/016458 was published on Jan. 25.Title of the invention: "PIPERAZINE DERIVATIVE."Applicants: ASTELLAS PHARMA INC. (JP).Inventors: Takashi Sugane (JP), Norio Asai (JP), Hiroyuki Moritomo (JP), Daisuke Yamashita (JP...
Form 8-K: Vical Files Current Report
US Fed News Service, Including US State News; January 23, 2018; 349 words
...Incorporation/State or other jurisdiction of incorporation: DelawareItem 8.01. Other Events.On January 22, 2018, Astellas Pharma Inc. and Vical Incorporated announced that ASP0113, an investigational DNA vaccine being developed for cytomegalovirus...
Rising from the Ashes of 'An Absolute Catastrophe'
The Boston Globe (Boston, MA); January 15, 2018; 700+ words
...2010 initial public offering.The following year, Aveo struck a cost-sharing partnership with another Japanese firm, Astellas Pharma Inc., in which Aveo would apply for US approval, while Astellas would tackle the European market.Results from early and...
Aveo CEO Says Biotech Is Rising from the Ashes of 'An Absolute Catastrophe'
The Boston Globe (Boston, MA); January 14, 2018; 700+ words
...2010 initial public offering.The following year, Aveo struck a cost-sharing partnership with another Japanese firm, Astellas Pharma Inc., in which Aveo would apply for US approval, while Astellas would tackle the European market.Results from early and...

Search HighBeam Business for more news about Astellas Pharma GmbH

Industry information

NAICS codes 
North American Industry Classification System (NAICS) codes are used to classify businesses for the purpose of collecting statistical data related to the U.S. economy. NAICS codes have been assigned to international companies to help organize all companies by type of activity.  

Primary: 325412 - Pharmaceutical Preparation Manufacturing

424210 - Drugs and Druggists' Sundries Merchant Wholesalers


 

SIC codes 
Standard Industrial Classification (SIC) codes classify establishments by their primary type of activity. SIC codes are a U.S. Census Bureau system but can apply to international companies.  

Primary: 2834 - Pharmaceutical Preparations industry report

5122 - Drugs, Drug Proprietaries, and Druggists' Sundries industry report